Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195756 | PMC |
| http://dx.doi.org/10.1007/s00262-021-02893-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Erratum: Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression: Erratum.
J Cancer
October 2024
Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China.
[This corrects the article DOI: 10.7150/jca.37932.
View Article and Find Full Text PDFSerum 5'-Nucleotidase as a Novel Predictor of Adverse Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease.
Rev Cardiovasc Med
January 2024
Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Background: The correlation between -Nucleotidase ( -NT) and the clinical outcomes in coronary artery disease (CAD) patients following percutaneous coronary intervention (PCI) is not clear. This study aims to clarify this relationship.
Methods: The PRACTICE study enrolled 15,250 patients between December 2016 and October 2021.
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
BMC Genomics
May 2024
Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
Background: Herein, we report results from a genome-wide study conducted to identify protein quantitative trait loci (pQTL) for circulating angiogenic and inflammatory protein markers in patients with metastatic colorectal cancer (mCRC). The study was conducted using genotype, protein marker, and baseline clinical and demographic data from CALGB/SWOG 80405 (Alliance), a randomized phase III study designed to assess outcomes of adding VEGF or EGFR inhibitors to systemic chemotherapy in mCRC patients. Germline DNA derived from blood was genotyped on whole-genome array platforms.
View Article and Find Full Text PDFCommon variation in a long non-coding RNA gene modulates variation of circulating TGF-2 levels in metastatic colorectal cancer patients (Alliance).
medRxiv
December 2023
Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Article Synopsis
- This study identified protein quantitative trait loci (pQTL) related to angiogenic and inflammatory proteins in patients with metastatic colorectal cancer (mCRC) using genetic and protein data from a large clinical trial.
- The analysis revealed a new pQTL associated with TGF-2 protein levels, validated in additional cancer patient datasets, and confirmed previously reported associations with VEGF-A and other protein markers.
- The findings enhance our understanding of how genetic variants influence protein levels in mCRC, potentially guiding future cancer treatments and research.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!